Pharmacists in Aventura, Florida


45 Pharmacists found in Aventura
male pharmacist

Nasser Moneir Khalil, RPH


Pharmacist
3007 Aventura Blvd, Aventura, FL 33180
305-936-2483    

female pharmacist

Dr. Natalia Leyva, PHARMD


Pharmacist
2952 Aventura Blvd, Aventura, FL 33180
305-792-1429    

female pharmacist

Mrs. Nenel Brisk, DOCTOR OF PHARMACY


Pharmacist
18995 Biscayne Blvd, Aventura, FL 33180
305-936-5767     305-692-3787



female pharmacist

Dr. Nicol Khan, PHARMD


Pharmacist
18071 Biscayne Blvd, Apt 901-3n, Aventura, FL 33160
786-284-8157    

female pharmacist

Mrs. Norma D Capasso


Pharmacist
2962 Aventura Blvd, Aventura, FL 33180
305-692-2499    

male pharmacist

Pavel A Permiachkine


Pharmacist
18995 Biscayne Blvd, Aventura, FL 33180
305-936-5767    

male pharmacist

Dr. Phanna Chhuor, PHARMD


Pharmacist
2962 Ne 199th St, Aventura, FL 33180
305-692-2499    

male pharmacist

Ramses Chalita


Pharmacist
3007 Aventura Blvd, Aventura, FL 33180
305-936-2483    

female pharmacist

Dr. Sindy S Dharampaul, DOCTOR OF PHARMACY


Pharmacist
20417 Biscayne Blvd, Aventura, FL 33180
305-935-3949     305-935-3943

female pharmacist

Sonya Farquharson, PHARMD.


Pharmacist
18665 Biscayne Blvd, Aventura, FL 33180
305-466-2844    

male pharmacist

Dr. Steven Johnson, PHARMD


Pharmacist
50 W Country Club Drive, 7th Floor, Aventura, FL 33180
305-662-8515    

male pharmacist

Vilen Polyak, PHARM. D


Pharmacist
18665 Biscayne Blvd, Aventura, FL 33180
305-496-6345    

female pharmacist

Yenly Caridad Garcia


Pharmacist
18665 Biscayne Blvd, Aventura, FL 33180
786-202-0444    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.